Acute Porphyria Drug Database

Monograph

B01AD10 - Drotrecogin Alfa (Activated)
Not porphyrinogenic
NP

Rationale
Recombinant enzyme. No CYP-interactions.
Chemical description
Recombinant activated protein C, which inactivates factor Va and VIIa and modulates the thrombotic response to infection. Administered as infusion in sepsis.

Similar drugs
Explore alternative drugs in similar therapeutic classes B01A / B01AD or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
United Kingdom
Xigris · Xigris 20mg powder for solution for infusion vials · Xigris 5mg powder for solution for infusion vials
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙